The Progress of Mitral Regurgitation after Isolated Coronary Artery Bypass in Cases of Ischemic Mitral Regurgitation
Background. Mitral valve intervention combined with coronary artery bypass surgery is inevitable in the case of severe mitral regurgitation in patients with coronary artery disease because the prognosis is poor without mitral correction. The best treatment protocol for patients with a moderate degree of mitral regurgitation is under debate. To clarify the optimal management for these patients, we evaluated the progress of mitral regurgitation after isolated coronary artery bypass surgery in cases of ischemic mitral regurgitation.
Methods. The study was conducted between March 2001 and April 2003. Forty-seven patients (70% men, with a mean age of 61 years, a mean ejection fraction of 43.7%, and a mean New York Heart Association class of 2.53) with preoperative diagnoses of moderate degree ischemic mitral regurgitation (Grade 3 mitral regurgitation on a scale of 0 to 4) and coronary artery disease, without leaflet pathology, underwent isolated coronary artery bypass surgery. Patients were followed-up at a mean of 22 months and an echocardiographic evaluation was done to determine the progress of the mitral disease.
Results. The 30-day operative mortality rate was 2.1%. In the postoperative period, the mean ejection fraction was 46.9% and the mean functional capacity of the patients was 1.31. Mitral regurgitation regressed to a mild degree in 56.9% of the patients. The 2-year survival rate was 93.7%.
Conclusions. Patients with moderate ischemic mitral regurgitation and coronary artery disease who underwent coronary artery bypass surgery alone had acceptable results. We are of the opinion that isolated coronary artery bypass surgery might be a good treatment choice for moderate degree ischemic mitral regurgitation.
Pinson CW, Cobanoglu A, Metzdorff MT, et al. 1984. Late surgical results for ischemic mitral regurgitation. Role of wall motion score and severity of regurgitation. J Thorac Cardiovasc Surg 88(5 Pt 1): 663-72.nDuarte IG, Shen Y, MacDonald MJ, et al. 1999. Treatment of moderate mitral regurgitation and coronary disease by coronary bypass alone: late results. Ann Thorac Surg 68:426-30.nFlameng W, Szecsi J, Sergeant P, et al. 1994. Combined valve and coronary artery bypass surgery: early and late results. Eur J Cardiothorac Surg 8:410-9; discussion 419.nGangemi JJ, Tribble CG, Ross SD, et al. 2000. Does the additive risk of mitral valve repair in patients with ischemic cardiomyopathy prohibit surgical intervention? Ann Surg 231:710-4.nHausmann H, Siniawski H, Hetzer R. 1999. Mitral valve reconstruction and replacement for ischemic mitral insufficiency: seven years' follow up. J Heart Valve Dis 8:536-42.nKim YH, Czer LSC, Soukiasian HJ, et al. 2005. Ischemic mitral regurgitation: revascularization alone versus revascularization and mitral valve repair. Ann Thorac Surg 79:1895-901nRankin JS, Hickey MS, Smith LR, et al. 1989. Current management of mitral valve incompetence associated with coronary artery disease. J Cardiac Surg 4:25-42.nRuvolo G, Speziale G, Bianchini R, et al. 1995. Combined coronary bypass grafting and mitral valve surgery: early and late results. Thorac Cardiovasc Surg 43:90-3.nVon Oppell UO, Stemmet F, Brink J, et al. 2000. Ischemic mitral valve >repair surgery. J Heart Valve Dis 9:64-73; discussion 73-4.nYun KL, Miller DC. 1991. Mitral valve repair versus replacement. Cardiol Clinics 9:315-27.nAdler DS, Goldman L, O'Neil A, et al. 1986. Long-term survival of more than 2,000 patients after coronary artery bypass grafting. Am J Cardiol 58:195-202.nAkins CW, Hilgenberg AD, Buckley MJ, et al. 1994. Mitral valve reconstruction versus replacement for degenerative or ischemic mitral regurgitation. Ann Thorac Surg 58:668-75; discussion 675-6.nAklog L, Filsoufi F, Flores KQ, et al. 2001. Does coronary artery bypass grafting alone correct moderate ischemic mitral regurgitation? Circulation 104(Suppl 1):I68-75.nArcidi JM Jr, Hebeler RF, Craver JM, et al. 1988. Treatment of moderate mitral regurgitation and coronary disease by coronary bypass alone. J Thorac Cardiovasc Surg 95:951-9.nBalu V, Hershowitz S, Zaki Masud AR, et al. 1982. Mitral regurgitation in coronary artery disease. Chest 81:550-5.nBolling SF, Deeb GM, Bach DS. 1996. Mitral valve reconstruction in elderly, ischemic patients. Chest 109:35-40. Chen FY, Adams DH, Aranki SF, et al. 1998. Mitral valve repair in cardiomyopathy. Circulation 98(19 Suppl):II124-7.nChristenson JT, Simonet F, Bloch A, et al. 1995. Should a mild to moderate ischemic mitral valve regurgitation in patients with poor left ventricular function be repaired or not? J Heart Valve Dis 4:484-8; discussion 488-9.nCohn LH, Rizzo RJ, Adams DH, et al. 1995. The effect of pathophysiology on the surgical treatment of ischemic mitral regurgitation: operative and late risks of repair versus replacement. Eur J Cardiothorac Surg 9: 568-74.nConnolly MW, Gelbfish JS, Jacobowitz, et al. 1986. Surgical results for mitral regurgitation from coronary artery disease. J Thorac Cardiovasc Surg 91:379-88.nDion R, Benetis R, Elias B, et al. 1995. Mitral valve procedures in ischemic regurgitation. J Heart Valve Dis 4(Suppl 2):S124-9; discussion S129-31.nGrigioni F, Enriquez-Sarano M, Zehr KJ, Bailey KR, Tajik AJ. 2001.nIschemic mitral regurgitation long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation 103: 1759-64.nHickey MS, Smith LR, Muhlbaier LH, et al. 1988. Current prognosis of ischemic mitral regurgitation: implications for future management. Circulation 78(3 Pt 2):I51-9.nIzhar U, Daly RC, Dearani JA, et al. 1999. Mitral valve replacement or repair after previous coronary artery bypass grafting. Circulation 100 (19 Suppl):II84-9.n
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).